Nontraditional Antibiotics—Challenges and Triumphs, 2nd Volume
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 24621
Special Issue Editor
Interests: antibiotics; antimicrobial resistance; polymyxins; peptide chemistry; peptide mimicry; drug discovery; organic synthesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first volume of the Special Issue “Nontraditional Antibiotics—Challenges and Triumphs” was published in 2019. It was a successful issue with nine published papers, encouraging us to open a second volume with the same topic.
This second volume aims to complement the 2019 Special Issue and invites submissions that highlight the current advances supporting the development and application of nontraditional antibiotic therapies. Topics may include but are not limited to:
- Antibodies, including antibody/antibiotic conjugates;
- Bacteriophages and lysins;
- Microbiome modulation;
- Narrow spectrum agents;
- Antibiotic potentiators and inactivators;
- Antimicrobial and immunomodulatory peptides;
- Biofilm disruptors;
- Virulence modulators;
- Targeted degradation approaches.
Dr. Karl Hansford
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nontraditional antibiotics
- bacteriophages
- lysins
- probiotics
- narrow spectrum agents
- antibiotic inactivators
- antibodies
- antimicrobial peptides
- immunomodulatory peptides
- antibiofilm
- antivirulence
- targeted protein degradation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.